
Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: a community-based cross-sectional study, August 2020
Author(s) -
Salil Sakalle,
Satish Saroshe,
Harish Shukla,
Anita Mutha,
Ameya Vaze,
Arpit Arora,
Aditya Athotra,
Sudarshan Ramaswamy,
Arania Jain,
Meera Dhuria,
Anil D Patil,
Arvind Rai,
Suneela Garg,
Sudhir Jain,
Jyoti Bindal,
Sujeet Kumar Singh
Publication year - 2021
Publication title -
journal of family medicine and primary care
Language(s) - English
Resource type - Journals
eISSN - 2278-7135
pISSN - 2249-4863
DOI - 10.4103/jfmpc.jfmpc_2015_20
Subject(s) - seroprevalence , medicine , asymptomatic , cross sectional study , population , antibody , herd immunity , immunology , veterinary medicine , serology , environmental health , pathology
In India, laboratory diagnosis of SARS - CoV-2 infection has been mostly based on real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Studies have shown that Viral titres peak within the first week of symptoms but may decline later hampering RT-PCR-based diagnostic strategies. Exact estimate is difficult under high-risk screening strategy with evidences of having large number of asymptomatic cases. This has prompted a call for adoption of antibody testing as potential source of data.